aluates Reports

$ 0.0

Automative

Global Latent Tuberculosis Infection (LTBI) Testing Market Research Report 2026

Published Date: 2026-02-27

Report Code: QYRE-Auto-0D9520

Global Latent Tuberculosis Infection LTBI Testing Market Size Status and Forecast 2022

BUY CHAPTERS

Global Latent Tuberculosis Infection (LTBI) Testing Market Research Report 2026

Code: QYRE-Auto-0D9520

Report

2026-02-27

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Qiagen NV

Oxford Immunotec

Thermo Fisher Scientific

Par Sterile

Bio Rad Laboratories

Sanofi

Latent Tuberculosis Infection (LTBI) Testing Market Size

The global Latent Tuberculosis Infection (LTBI) Testing market was valued at US$ 1625 million in 2025 and is anticipated to reach US$ 2336 million by 2032, at a CAGR of 5.4% from 2026 to 2032.

Latent Tuberculosis Infection (LTBI) Testing Market

The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.

Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.

Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.

The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.

Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.

Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.

This report delivers a comprehensive overview of the global Latent Tuberculosis Infection (LTBI) Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Latent Tuberculosis Infection (LTBI) Testing. The Latent Tuberculosis Infection (LTBI) Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Latent Tuberculosis Infection (LTBI) Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Latent Tuberculosis Infection (LTBI) Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Latent Tuberculosis Infection (LTBI) Testing Market Report

Report Metric	Details
Report Name	Latent Tuberculosis Infection (LTBI) Testing Market
Accounted market size in 2025	US$ 1625 million
Forecasted market size in 2032	US$ 2336 million
CAGR	5.4%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Tuberculin Skin Test (TST) Interferon Gamma Released Assay (IGRA)
Segment by Application	Hospitals and Clinics Diagnostic Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, Par Sterile, Bio-Rad Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Latent Tuberculosis Infection (LTBI) Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Latent Tuberculosis Infection (LTBI) Testing Market growing?

Ans: The Latent Tuberculosis Infection (LTBI) Testing Market witnessing a CAGR of 5.4% during the forecast period 2026-2032.

What is the Latent Tuberculosis Infection (LTBI) Testing Market size in 2032?

Ans: The Latent Tuberculosis Infection (LTBI) Testing Market size in 2032 will be US$ 2336 million.

Who are the main players in the Latent Tuberculosis Infection (LTBI) Testing Market report?

Ans: The main players in the Latent Tuberculosis Infection (LTBI) Testing Market are Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, Par Sterile, Bio-Rad Laboratories

What are the Application segmentation covered in the Latent Tuberculosis Infection (LTBI) Testing Market report?

Ans: The Applications covered in the Latent Tuberculosis Infection (LTBI) Testing Market report are Hospitals and Clinics, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Latent Tuberculosis Infection (LTBI) Testing Market report?

Ans: The Types covered in the Latent Tuberculosis Infection (LTBI) Testing Market report are Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Tuberculin Skin Test (TST)

1.2.3 Interferon Gamma Released Assay (IGRA)

1.3 Market by Application

1.3.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals and Clinics

1.3.3 Diagnostic Laboratories

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2021–2032)

2.2 Global Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Region

2.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Region (2021–2026)

2.2.3 Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Region (2027–2032)

2.3 Latent Tuberculosis Infection (LTBI) Testing Market Dynamics

2.3.1 Latent Tuberculosis Infection (LTBI) Testing Industry Trends

2.3.2 Latent Tuberculosis Infection (LTBI) Testing Market Drivers

2.3.3 Latent Tuberculosis Infection (LTBI) Testing Market Challenges

2.3.4 Latent Tuberculosis Infection (LTBI) Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue

3.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2021–2026)

3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2021–2026)

3.2 Global Top Latent Tuberculosis Infection (LTBI) Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue

3.4 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio

3.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2025

3.5 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing Head Offices and Areas Served

3.6 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Products and Applications

3.7 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Type

4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2021–2026)

4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2027–2032)

5 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Application

5.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Application (2021–2026)

5.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2021–2032)

6.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021–2026)

6.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2021–2032)

7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021–2026)

7.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size (2021–2032)

8.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2021–2026)

8.4 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size (2021–2032)

9.2 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021–2026)

9.4 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size (2021–2032)

10.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2021–2026)

10.4 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Qiagen

11.1.1 Qiagen Company Details

11.1.2 Qiagen Business Overview

11.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction

11.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

11.1.5 Qiagen Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Introduction

11.2.4 Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

11.2.5 Sanofi Recent Development

11.3 Oxford Immunotec

11.3.1 Oxford Immunotec Company Details

11.3.2 Oxford Immunotec Business Overview

11.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Introduction

11.3.4 Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

11.3.5 Oxford Immunotec Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction

11.4.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Par Sterile

11.5.1 Par Sterile Company Details

11.5.2 Par Sterile Business Overview

11.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Introduction

11.5.4 Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

11.5.5 Par Sterile Recent Development

11.6 Bio-Rad Laboratories

11.6.1 Bio-Rad Laboratories Company Details

11.6.2 Bio-Rad Laboratories Business Overview

11.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction

11.6.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

11.6.5 Bio-Rad Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Qiagen NV

Oxford Immunotec

Thermo Fisher Scientific

Par Sterile

Bio Rad Laboratories

Sanofi

List of Tables

Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Tuberculin Skin Test (TST)

Table 3. Key Players of Interferon Gamma Released Assay (IGRA)

Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (US$ Million), 2021–2026

Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2021–2026)

Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2027–2032)

Table 10. Latent Tuberculosis Infection (LTBI) Testing Market Trends

Table 11. Latent Tuberculosis Infection (LTBI) Testing Market Drivers

Table 12. Latent Tuberculosis Infection (LTBI) Testing Market Challenges

Table 13. Latent Tuberculosis Infection (LTBI) Testing Market Restraints

Table 14. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Players (US$ Million), 2021–2026

Table 15. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players (2021–2026)

Table 16. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Latent Tuberculosis Infection (LTBI) Testing Revenue, 2025

Table 17. Ranking of Global Top Latent Tuberculosis Infection (LTBI) Testing Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Headquarters and Area Served

Table 20. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Products and Applications

Table 21. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (US$ Million), 2021–2026

Table 24. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2021–2026)

Table 25. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2027–2032)

Table 27. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (US$ Million), 2021–2026

Table 28. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2021–2026)

Table 29. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2027–2032)

Table 31. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (US$ Million), 2021–2026

Table 33. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (US$ Million), 2027–2032

Table 46. Qiagen Company Details

Table 47. Qiagen Business Overview

Table 48. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product

Table 49. Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (US$ Million), 2021–2026

Table 50. Qiagen Recent Development

Table 51. Sanofi Company Details

Table 52. Sanofi Business Overview

Table 53. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product

Table 54. Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (US$ Million), 2021–2026

Table 55. Sanofi Recent Development

Table 56. Oxford Immunotec Company Details

Table 57. Oxford Immunotec Business Overview

Table 58. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product

Table 59. Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (US$ Million), 2021–2026

Table 60. Oxford Immunotec Recent Development

Table 61. Thermo Fisher Scientific Company Details

Table 62. Thermo Fisher Scientific Business Overview

Table 63. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product

Table 64. Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (US$ Million), 2021–2026

Table 65. Thermo Fisher Scientific Recent Development

Table 66. Par Sterile Company Details

Table 67. Par Sterile Business Overview

Table 68. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product

Table 69. Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (US$ Million), 2021–2026

Table 70. Par Sterile Recent Development

Table 71. Bio-Rad Laboratories Company Details

Table 72. Bio-Rad Laboratories Business Overview

Table 73. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product

Table 74. Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (US$ Million), 2021–2026

Table 75. Bio-Rad Laboratories Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. Latent Tuberculosis Infection (LTBI) Testing Picture

Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type: 2025 vs 2032

Figure 4. Tuberculin Skin Test (TST) Features

Figure 5. Interferon Gamma Released Assay (IGRA) Features

Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2025 vs 2032

Figure 8. Hospitals and Clinics Case Studies

Figure 9. Diagnostic Laboratories Case Studies

Figure 10. Others Case Studies

Figure 11. Latent Tuberculosis Infection (LTBI) Testing Report Years Considered

Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Latent Tuberculosis Infection (LTBI) Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region: 2025 vs 2032

Figure 15. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players in 2025

Figure 16. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2025

Figure 18. North America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021–2032)

Figure 20. United States Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021–2032)

Figure 24. Germany Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2021–2032)

Figure 32. China Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021–2032)

Figure 40. Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2021–2032)

Figure 44. Israel Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Qiagen Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

Figure 48. Sanofi Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

Figure 49. Oxford Immunotec Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

Figure 51. Par Sterile Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2021–2026)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Latent Tuberculosis Infection Screening Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Latent TB Infection Testing Market Research Report 2024

Tuberculosis Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Latent Tuberculosis Infection Detection Market Research Report 2024

Global Latent tuberculosis Testing Market Research Report 2024

Global Laboratory Developed Tests LDT Market Research Report 2025

Tuberculosis Testing and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tuberculosis Infection Testing Market Research Report 2024

Tuberculosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tuberculin Skin Test TST Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

HIV Self Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pathogen Testing Market Research Report 2024

Global Legionella Testing Kits Market Insights Forecast to 2030

Global Mycobacterium Tuberculosis Testing Market Research Report 2024

Global Food Safety Rapid Test Kit Market Research Report 2024

Global DTC Testing Market Insights Forecast to 2030

Tuberculosis Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tuberculosis TB Diagnostics Market Research Report 2025

Global Food Safety Testing and Analysis Service Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions